Next Article in Journal
Comparison between N-803 and Erdafitinib in Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer
Previous Article in Journal
Immunotherapeutic Potential of Mutated NPM1 for the Treatment of Acute Myeloid Leukemia
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 16
Issue 20
10.3390/cancers16203444
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Cancers 2021, 13(20), 5197.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Mansoori et al. HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer. Cancers 2021, 13, 5197

by
Behzad Mansoori
1,2,3,
Mikkel Green Terp
2,
Ali Mohammadi
2,
Christina Bøg Pedersen
2,
Henrik Jørn Ditzel
2,4,5,
Behzad Baradaran
1 and
Morten Frier Gjerstorff
2,4,5,*
1
Immunology Research Center, Tabriz University of Medical Sciences, Golghasht St., Tabriz 51666-14731, Iran
2
Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, J. B. Winsløws Vej 25, 3, DK-5000 Odense C, Denmark
3
Aging Research Institute, Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Sciences, Golghasht St., Tabriz 51656-65811, Iran
4
Department of Oncology, Odense University Hospital, DK-5000 Odense C, Denmark
5
Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, DK-5000 Odense C, Denmark
*
Author to whom correspondence should be addressed.
Cancers 2024, 16(20), 3444; https://doi.org/10.3390/cancers16203444
Submission received: 19 July 2024 / Accepted: 25 July 2024 / Published: 11 October 2024
Browse Figures
Versions Notes

Error in Figures

In the original publication [1], there was a mistake in Figures 4A,C and 7A as published. Duplicated images due to errors in our figure preparation process. The corrected Figure 4A,C and Figure 7A appear below. Additionally, the associated supplementary figure has been updated to reflect this correction. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Mansoori, B.; Terp, M.G.; Mohammadi, A.; Pedersen, C.B.; Ditzel, H.J.; Baradaran, B.; Gjerstorff, M.F. HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer. Cancers 2021, 13, 5197. [Google Scholar] [CrossRef] [PubMed]
Cancers 16 03444 g004
Figure 4. HMGA2 silencing decreases the invasion and migration of TNBC cells. Micrograph showing reduced invasion of HMGA2-silenced TNBC cells compared to corresponding TNBC control cells (A). The number of HMGA2-silenced migrated cells were quantified and compared to shScramble cells for both MDA-MB-231 and Cal-51 cell lines after 48 h treatment with or without doxycycline (Dox) (B). Micrograph showing that HMGA2-silenced TNBC cells exhibit reduced invasion (decreased cell migration into the wound gap area) compared to corresponding TNBC control cells (Magnification, ×20) (C). The wound area width was quantified and compared to that of shScramble cells for both cell lines (D). The results are shown as mean ± SD (n = 3) versus shScramble cells, ** p < 0.01, **** p < 0.0001 by t-test.
Figure 4. HMGA2 silencing decreases the invasion and migration of TNBC cells. Micrograph showing reduced invasion of HMGA2-silenced TNBC cells compared to corresponding TNBC control cells (A). The number of HMGA2-silenced migrated cells were quantified and compared to shScramble cells for both MDA-MB-231 and Cal-51 cell lines after 48 h treatment with or without doxycycline (Dox) (B). Micrograph showing that HMGA2-silenced TNBC cells exhibit reduced invasion (decreased cell migration into the wound gap area) compared to corresponding TNBC control cells (Magnification, ×20) (C). The wound area width was quantified and compared to that of shScramble cells for both cell lines (D). The results are shown as mean ± SD (n = 3) versus shScramble cells, ** p < 0.01, **** p < 0.0001 by t-test.
Cancers 16 03444 g004
Cancers 16 03444 g007
Figure 7. HMGA2 silencing decreased activation of NF-kB/IL-6/STAT3 signaling. Western blotting showed that doxycycline (Dox)-induced HMGA2 silencing (shHMGA2) decreased both NF-kB-p65 (A,B), p-NF-kB-p65 (A,C) and p-STAT3 (A,E) but not STAT3 (A,D) protein levels. In addition, HMGA2 silencing decreased IL-6 (F,G) and IL-8 (H,I) in both the mRNA and protein levels (n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 by t-test versus the shScramble group.
Figure 7. HMGA2 silencing decreased activation of NF-kB/IL-6/STAT3 signaling. Western blotting showed that doxycycline (Dox)-induced HMGA2 silencing (shHMGA2) decreased both NF-kB-p65 (A,B), p-NF-kB-p65 (A,C) and p-STAT3 (A,E) but not STAT3 (A,D) protein levels. In addition, HMGA2 silencing decreased IL-6 (F,G) and IL-8 (H,I) in both the mRNA and protein levels (n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 by t-test versus the shScramble group.
Cancers 16 03444 g007
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mansoori, B.; Terp, M.G.; Mohammadi, A.; Pedersen, C.B.; Ditzel, H.J.; Baradaran, B.; Gjerstorff, M.F. Correction: Mansoori et al. HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer. Cancers 2021, 13, 5197. Cancers 2024, 16, 3444. https://doi.org/10.3390/cancers16203444

AMA Style

Mansoori B, Terp MG, Mohammadi A, Pedersen CB, Ditzel HJ, Baradaran B, Gjerstorff MF. Correction: Mansoori et al. HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer. Cancers 2021, 13, 5197. Cancers. 2024; 16(20):3444. https://doi.org/10.3390/cancers16203444

Chicago/Turabian Style

Mansoori, Behzad, Mikkel Green Terp, Ali Mohammadi, Christina Bøg Pedersen, Henrik Jørn Ditzel, Behzad Baradaran, and Morten Frier Gjerstorff. 2024. "Correction: Mansoori et al. HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer. Cancers 2021, 13, 5197" Cancers 16, no. 20: 3444. https://doi.org/10.3390/cancers16203444

APA Style

Mansoori, B., Terp, M. G., Mohammadi, A., Pedersen, C. B., Ditzel, H. J., Baradaran, B., & Gjerstorff, M. F. (2024). Correction: Mansoori et al. HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer. Cancers 2021, 13, 5197. Cancers, 16(20), 3444. https://doi.org/10.3390/cancers16203444

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop